Prodia Diagnostic Line Tbk vs Summarecon Agung Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp272 (market cap 470.58B, 41.8K 24h volume), while Summarecon Agung Tbk. trades at Rp324 (market cap 5.38T, 85K 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 11.4× Prodia Diagnostic Line Tbk's market cap, and Summarecon Agung Tbk. is more actively traded (85K versus 41.8K). Which is the better fit depends on your goals.
| PRDL | SMRA | |
|---|---|---|
Market Cap | 470.58B | 5.38T |
Volume | 41.8K | 85K |
Lot | 418 | 850 |
Turnover | 11.37M | 27.54M |
Average Price | 272 | 324 |
Value | 11.37M | 27.54M |
Indicative Equilibrium Price | 272 | 324 |
Indicative Equilibrium Volume | 418 | 850 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →